dc.contributor.author
Darbà, Josep
dc.contributor.author
Ascanio, Meritxell
dc.date.issued
2025-04-09T08:15:53Z
dc.date.issued
2025-04-09T08:15:53Z
dc.date.issued
2025-04-01
dc.date.issued
2025-04-09T08:15:53Z
dc.identifier
https://hdl.handle.net/2445/220360
dc.description.abstract
Hepatocellular carcinoma (HCC), which accounts for about 90% of all primary liver can-cer cases, is the fifth most common malignancy and the second leading cause of cancer-related mor-tality worldwide. This study aims to analyse the differential costs of HCC-related hospital admissionscompared to the general population in Spain (...)
dc.format
application/pdf
dc.publisher
Taylor & Francis
dc.relation
Reproducció del document publicat a: https://doi.org/https://doi.org/10.1080/13696998.2025.2484073
dc.relation
Journal of Medical Economics, 2025, vol. 28, num.1, p. 471-478
dc.relation
https://doi.org/https://doi.org/10.1080/13696998.2025.2484073
dc.rights
(c) Taylor & Francis, 2025
dc.rights
http://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Economia)
dc.subject
Control de costos
dc.subject
Economia de la salut
dc.subject
Política sanitària
dc.subject
Carcinogenesis
dc.subject
Medical economics
dc.subject
Medical policy
dc.title
Hepatocellular carcinoma: what are the differential costs compared to the general population?
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion
